Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels-Reference-Cited by-同舟云学术

Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels

Published:2023-03 Issue: Volume:28 Page:46-58
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Lv Jiang,Qin Le,Zhao Ruocong,Wu Di,Wu Zhiping,Zheng Diwei,Li Siyu,Luo Mintao,Wu Qiting,Long Youguo,Tang Zhaoyang,Tang Yan-Lai,Luo Xuequn,Yao Yao,Yang Li-Hua,Li Peng^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference74 articles.

1. CAR T cell therapy for solid tumors;Newick;Annu. Rev. Med.,2017

2. Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes;Roselli;J. Clin. Invest.,2021

3. CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment;Martinez;Front. Immunol.,2019

4. Harnessing cytokines and chemokines for cancer therapy;Propper;Nat. Rev. Clin. Oncol.,2022

5. PD-1 and its ligands in tolerance and immunity;Keir;Annu. Rev. Immunol.,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy;Frontiers in Immunology;2024-09-09

2. Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapy;2024-09-07

3. Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets;Experimental Hematology & Oncology;2024-08-30

4. Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review;Frontiers in Oncology;2024-06-07

5. Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways;Experimental Hematology & Oncology;2024-04-23